Biogen Pharmachem Industries Sets Record Date for 1:6 Bonus Share Issuance
Biogen Pharmachem Industries Limited has set May 15, 2026, as the record date for its 1:6 bonus share issuance, where shareholders will receive 1 new equity share of Rs.1/- for every 6 existing shares. The proposal requires shareholder approval via postal ballot and e-voting, with the company maintaining full regulatory compliance under SEBI LODR requirements.

*this image is generated using AI for illustrative purposes only.
Biogen Pharmachem Industries Limited has announced the record date for its upcoming bonus share issuance, marking a significant corporate action for existing shareholders. The company has set Friday, May 15, 2026, as the crucial date for determining shareholder eligibility for the proposed bonus equity shares.
Bonus Share Details
The company has proposed issuing bonus shares in an attractive 1:6 ratio, providing substantial value to existing shareholders. Under this arrangement, eligible shareholders will receive 1 new equity share of Rs.1/- each for every 6 existing equity shares of Rs.1/- each that are fully paid up.
| Parameter: | Details |
|---|---|
| Record Date: | Friday, May 15, 2026 |
| Bonus Ratio: | 1:6 |
| New Share Value: | Rs.1/- each |
| Existing Share Value: | Rs.1/- each |
| Share Status: | Fully paid up |
Regulatory Compliance
The announcement has been made in compliance with Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has formally communicated this information to BSE Limited, where its shares are listed under scrip code 531752 and scrip ID BIOGEN.
Shareholder Approval Process
The bonus share issuance remains subject to shareholder approval, which the company is obtaining through postal ballot including e-voting facilities. This process ensures compliance with applicable laws and regulations while providing convenient voting options for shareholders.
Corporate Communication
The notification was signed by Kelash Bunkar, Wholetime Director with DIN 10911360, on April 1, 2026. The company has indicated that this information will also be made available on its official website at www.biogenpharma.bar for broader accessibility to stakeholders.
Company Information
Biogen Pharmachem Industries Limited operates from its registered office located at Shop No. 8, First Floor, Makers – 1 Building, Jawahar Road, Rajkot-360001. The company maintains communication through its official email biogenpharmachem@gmail.com and continues to fulfill its disclosure obligations as a listed entity.
Historical Stock Returns for Biogen Pharmachem
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.33% | +11.54% | -13.43% | -30.95% | -40.82% | +163.64% |
What impact will the 1:6 bonus share issuance have on Biogen Pharmachem's stock price and trading liquidity post-implementation?
How might this bonus share announcement influence investor sentiment toward other pharmaceutical companies in similar market segments?
What are the potential outcomes if shareholders reject the bonus share proposal during the postal ballot voting process?






























